22nd Century to Participate in September and October 2021 Investor Conferences
September 27 2021 - 4:30PM
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural
biotechnology and intellectual property company focused on
improving health and wellness through plant science, today
announced that the Company will participate in the following
virtual investor conferences during the months of September and
October 2021:
- On Wednesday, September 29, 2021, at 8:50 a.m. ET, the Company
will host a fireside chat at the BTIG Cannabis Conference.
BTIG-hosted events are intended for prospective and existing BTIG
clients only. To listen to the live event, please contact your BTIG
representative.
- On Tuesday, October 12, 2021, at 9:30 a.m. ET, the Company will
conduct a virtual presentation at the 2021 LD Micro Main Event
Conference. A webcast will be available via a link on the Company’s
Investor Relations website under the Events subtab at:
www.xxiicentury.com/investors/events
- On Thursday, October 21, 2021, at 10:00 a.m. ET, the Company
will be present at the 2021 Dawson James Sixth Small Cap Growth
Stock Conference. A webcast of the group presentation will be
available via the Company’s Investor Relations website under the
Events subtab at: www.xxiicentury.com/investors/events
During his presentations, James A. Mish, chief executive officer
of 22nd Century Group, will highlight the Company’s business
development, commercialization, and value creation efforts across
its three high-value plant-based franchises. He will discuss plans
for commercializing VLN® reduced nicotine content cigarettes
in the U.S. and international markets, expectations for monetizing
proprietary hemp/cannabis plant lines and IP by the end of this
year, and the Company’s development plans following its recently
announced entry into the specialty hops market.
Institutional investors and those invited to attend these
virtual conference events may request one-on-one meetings with
representatives of the Company, where offered, through the
respective conference hosts or by contacting 22nd Century Group’s
investor relations team via investorrelations@xxiicentury.com.
22nd Century Group, Inc. (Nasdaq: XXII) is a leading
agricultural biotechnology and intellectual property company
focused on improving health and wellness through plant science.
22nd Century uses modern plant breeding technologies, gene-editing,
and molecular breeding to deliver value to its customers in the
life science and consumer products industries by creating new,
proprietary tobacco, hemp/cannabis and hop plants with optimized
alkaloid and flavonoid profiles as well as improved yields and
valuable agronomic traits. 22nd Century was founded to build
intellectual property related to nicotine biosynthesis in the
tobacco plant and to commercialize its proprietary reduced nicotine
content (RNC) tobacco plants, which have become the cornerstone of
FDA’s Comprehensive Plan to address the enormous amount of death
and disease caused by addiction to smoking. The Company has also
begun to leverage its plant science expertise and existing
partnerships to create and commercialize new, proprietary
hemp/cannabis and hop plants to optimize their genetics and create
valuable new intellectual property.
Learn more at xxiicentury.com, on
Twitter @_xxiicentury, and on LinkedIn.
Cautionary Note Regarding Forward-Looking
StatementsExcept for historical information, all of the
statements, expectations, and assumptions contained in this press
release are forward-looking statements. Forward-looking statements
typically contain terms such as “anticipate,” “believe,”
“consider,” “continue,” “could,” “estimate,” “expect,” “explore,”
“foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,”
“potential,” “predict,” “preliminary,” “probable,” “project,”
“promising,” “seek,” “should,” “will,” “would,” and similar
expressions. Actual results might differ materially from those
explicit or implicit in forward-looking statements. Important
factors that could cause actual results to differ materially are
set forth in “Risk Factors” in the Company’s Annual Report on Form
10-K filed on March 11, 2021. All information provided in this
release is as of the date hereof, and the Company assumes no
obligation to and does not intend to update these forward-looking
statements, except as required by law.
Investor Relations & Media
Contact:Mei KuoDirector, Communications & Investor
Relations22nd Century Group, Inc.(716)
300-1221mkuo@xxiicentury.com
22nd Century (NASDAQ:XXII)
Historical Stock Chart
From Mar 2024 to Apr 2024
22nd Century (NASDAQ:XXII)
Historical Stock Chart
From Apr 2023 to Apr 2024